Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The US Oncology Network Selects Myriad Genetics as Preferred Provider for Hereditary Cancer Testing
The US Oncology Network Selects Myriad Genetics as Preferred Provider for Hereditary Cancer Testing
The US Oncology Network Selects Myriad Genetics as Preferred Provider for Hereditary Cancer Testing
Submitted by
admin
on October 4, 2016 - 9:42am
Source:
Cafepharma/Globe Newswire
News Tags:
Myriad Genetics
oncology
diagnostics
cancer
Headline:
The US Oncology Network Selects Myriad Genetics as Preferred Provider for Hereditary Cancer Testing
Do Not Allow Advertisers to Use My Personal information
